483 Nanjing King-Friend Biochemical Pharmaceutical Apr 2018

483 Nanjing King-Friend Biochemical Pharmaceutical Apr 2018

Darren Brown FDA, Djamila Harouaka FDA, Ruo Xu FDA$119.00 - Available Now

FDA investigators audited the Nanjing King-Friend Biochemical Pharmaceutical - Nanjing, China facility and issued inspectional observations (via FDA 483) on 03 Apr 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 03 Apr 2018
  • Location: Nanjing, China
  • FEI: 3010625707
Add To Cart